Medicines labeled for the same conditions
Alternatives to brimonidine and brinzolamide
14 other medicines are given the same way (ophthalmic) and in the same FDA class as brimonidine and brinzolamide or labeled mainly for the same use (glaucoma); 2 are in its class, carbonic anhydrase inhibitors: dorzolamide and timolol and dorzolamide; the others include 4 prostaglandin analogs, 3 beta-adrenergic blockers and 2 rho kinase inhibitors (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $0.835 per mL (Dorzolamide HCl 2% eye drops) (what pharmacies paid in the NADAC survey; strengths differ).
Which medicines are labeled for the same conditions as brimonidine and brinzolamide?
Glaucoma lists all 20 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (ophthalmic) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Brimonidine and brinzolamidecarbonic anhydrase inhibitor | this medicine | none listed | $26.04 per mL 1%-0.2% eye drop | No | No current entry |
| Dorzolamide and timololcarbonic anhydrase inhibitor · same class | Glaucoma | 14 labelers | $0.893 per mL Dorzolamide-timolol eye drops | No | No current entry |
| Dorzolamidecarbonic anhydrase inhibitor · same class | Glaucoma | 14 labelers | $0.835 per mL 2% eye drops | No | No current entry |
| Timololbeta-adrenergic blocker | Glaucoma | 21 labelers | $0.774 per mL 0.5% eye drops | No | No current entry |
| Bimatoprostprostaglandin analog | Glaucoma | 13 labelers | $6.97 per mL 0.03% eye drops | No | No current entry |
| Latanoprostprostaglandin analog | Glaucoma | 14 labelers | $1.58 per mL 0.005% eye drops | No | No current entry |
| Travoprostprostaglandin analog | Glaucoma | 11 labelers | $9.07 per mL 0.004% eye drop | No | A presentation being discontinued |
| Pilocarpinecholinergic receptor agonist | Glaucoma | 2 labelers | $2.81 per mL 2% eye drops | No | A presentation being discontinued |
| Tafluprostprostaglandin analog | Glaucoma | 3 labelers | $2.45 per unit 0.0015% eye drop | No | No current entry |
| Latanoprostene bunod | Glaucoma | 1 labeler | $102.27 per mL 0.024% eye solution | No | No current entry |
| Carteololbeta-adrenergic blocker | Glaucoma | 1 labeler | $1.63 per mL 1% eye drops | No | No current entry |
| Latanoprost and netarsudilrho kinase inhibitor | Glaucoma | none listed | $139.40 per mL 0.02%-0.005% eye drp | No | No current entry |
| Levobunololbeta-adrenergic blocker | Glaucoma | 1 labeler | $2.82 per mL 0.5% eye drops | No | No current entry |
| Netarsudilrho kinase inhibitor | Glaucoma | none listed | $131.68 per mL 0.02% eye solution | No | No current entry |
| Omidenepag isopropylprostaglandin e2 receptor agonist | Glaucoma | none listed | n/a | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Brimonidine and brinzolamide: the full record
- label, generics, price, shortages, recalls